Literature DB >> 23532995

miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells.

Luc Gailhouste1, Laura Gomez-Santos, Keitaro Hagiwara, Izuho Hatada, Noriyuki Kitagawa, Kazushi Kawaharada, Muriel Thirion, Nobuyoshi Kosaka, Ryou-U Takahashi, Tatsuhiro Shibata, Atsushi Miyajima, Takahiro Ochiya.   

Abstract

UNLABELLED: MicroRNAs (miRNAs) are evolutionary conserved small RNAs that post-transcriptionally regulate the expression of target genes. To date, the role of miRNAs in liver development is not fully understood. By using an experimental model that allows the induced and controlled differentiation of mouse fetal hepatoblasts (MFHs) into mature hepatocytes, we identified miR-148a as a hepatospecific miRNA highly expressed in adult liver. The main finding of this study revealed that miR-148a was critical for hepatic differentiation through the direct targeting of DNA methyltransferase (DNMT) 1, a major enzyme responsible for epigenetic silencing, thereby allowing the promotion of the "adult liver" phenotype. It was also confirmed that the reduction of DNMT1 by RNA interference significantly promoted the expression of the major hepatic biomarkers. In addition to the essential role of miR-148a in hepatocyte maturation, we identified its beneficial effect through the repression of hepatocellular carcinoma (HCC) cell malignancy. miR-148a expression was frequently down-regulated in biopsies of HCC patients as well as in mouse and human HCC cell lines. Overexpressing miR-148a led to an enhancement of albumin production and a drastic inhibition of the invasive properties of HCC cells, whereas miR-148a silencing had the opposite consequences. Finally, we showed that miR-148a exerted its tumor-suppressive effect by regulating the c-Met oncogene, regardless of the DNMT1 expression level.
CONCLUSION: miR-148a is essential for the physiology of the liver because it promotes the hepatospecific phenotype and acts as a tumor suppressor. Most important, this report is the first to demonstrate a functional role for a specific miRNA in liver development through regulation of the DNMT1 enzyme.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532995     DOI: 10.1002/hep.26422

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  63 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 2.  Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.

Authors:  Chun-Ming Wong; Felice Ho-Ching Tsang; Irene Oi-Lin Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-10       Impact factor: 46.802

Review 3.  The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Chikako Shibata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-11-21       Impact factor: 7.527

Review 4.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 5.  Developments in miRNA gene signaling pathways in pancreatic cancer.

Authors:  Christina Vorvis; Marina Koutsioumpa; Dimitrios Iliopoulos
Journal:  Future Oncol       Date:  2016-03-17       Impact factor: 3.404

6.  miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1.

Authors:  Alan P Lombard; Benjamin A Mooso; Stephen J Libertini; Rebecca M Lim; Rachel M Nakagawa; Kathleen D Vidallo; Nicole C Costanzo; Paramita M Ghosh; Maria Mudryj
Journal:  Mol Carcinog       Date:  2015-04-11       Impact factor: 4.784

7.  Interaction of Insulin Resistance and Related Genetic Variants With Triglyceride-Associated Genetic Variants.

Authors:  Yann C Klimentidis; Amit Arora
Journal:  Circ Cardiovasc Genet       Date:  2016-02-05

8.  MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1.

Authors:  Kwang Hwa Jung; Ryan L McCarthy; Chong Zhou; Nadima Uprety; Michelle Craig Barton; Laura Beretta
Journal:  Stem Cells       Date:  2016-02-01       Impact factor: 6.277

9.  DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration.

Authors:  Kosuke Kaji; Valentina M Factor; Jesper B Andersen; Marian E Durkin; Akira Tomokuni; Jens U Marquardt; Matthias S Matter; Tanya Hoang; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2016-04-28       Impact factor: 17.425

10.  miR-133b Regulation of Connective Tissue Growth Factor: A Novel Mechanism in Liver Pathology.

Authors:  Altin Gjymishka; Liya Pi; Seh-Hoon Oh; Marda Jorgensen; Chen Liu; Yianni Protopapadakis; Ashnee Patel; Bryon E Petersen
Journal:  Am J Pathol       Date:  2016-03-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.